Dan Janney is listed as a director on 5 SEC Form D filings by 3 issuers between Nov 2009 and May 2018: Allakos Inc. (San Carlos, CA — biotechnology — 2017; $100.1M reported sold to 40 investors), SARcode Bioscience Inc. (Brisbane, CA — biotechnology — 2009; $43.6M reported sold to 9 investors) and PROLACTA BIOSCIENCE INC (Duarte, CA — biotechnology — 2016–2018; $35M reported sold to 20 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 9 years. Across those companies the filings report $178.7M sold in total.
Listed alongside Robert Alexander (3 shared filings), David Brailer (2 shared filings), Dennis Henner (2 shared filings), Emmett Cunningham (2 shared filings), Ernie Strapazon (2 shared filings) and 22 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Dan Janney and found 5 differences: Form D filed 18 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.